Affiliation:
1. The University of St. Andrews
2. The University of Queensland
Abstract
Ready access to synthetic DNA has enabled vast progress in health and biotechnology in recent decades. However, it also makes it easier for malicious actors to develop biological weapons that threaten public health. Thus, it is crucial to regulate who can order synthetic DNA of pathogens from commercial providers. Some synthetic DNA providers screen customers and ordered sequences; however, there is no federal legislation addressing the responsibilities of these companies. Voluntary compliance with the screening Guidance issued by the US Department of Health and Human Services (HHS) is not sustainable, as it disadvantages companies who screen against those who do not. Here, we consider two policy solutions. Option 1 is to mandate minimum screening standards for all US-based synthetic DNA providers. This regulatory burden may weaken the US DNA synthesis sector, so we recommend Option 2, which requires government-funded researchers to only use synthetic DNA from accredited screening-compliant providers.
Publisher
Journal of Science Policy and Governance, Inc.
Subject
Environmental Engineering
Reference22 articles.
1. Anderson, Iain. 2008. Foot and Mouth Disease 2007: A Review and Lessons Learned. (House of Commons). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/250363/0312.pdf.
2. Balaji, Advait, Bryce Kille, Anthony D. Kappell, Gene D. Godbold, Madeline Diep, R. A. Leo Elworth, Zhiqin Qian, Dreycey Albin, Daniel J. Nasko, Nidhi Shah, Mihai Pop, Santiago Segarra, Krista L. Ternus, and Todd J. Treangen. 2022. ""SeqScreen: accurate and sensitive functional screening of pathogenic sequences via ensemble learning."" Genome Biology 23 (1): 133. https://doi.org/10.1186/s13059-022-02695-x.
3. Boroush, Mark. 2022. U.S. R&D Increased by $62 Billion in 2019 to $667 Billion
4. Estimate for 2020 Indicates a Further Rise to $708 Billion. (National Center for Science and Engineering Statistics). https://ncses.nsf.gov/pubs/nsf22330.
5. California State Legislature. 2022. AB-1963: California State University and University of California: gene synthesis providers. https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202120220AB1963.